Pricey gene therapies expected to ‘dominate’ talk at JP Morgan conference – Boston Business Journal
Boston Business Journal |
Pricey gene therapies expected to 'dominate' talk at JP Morgan conference
Boston Business Journal If you're a biotech industry executive or investor, chances are you're in San Francisco this week for the annual J.P. Morgan healthcare conference. And you can expect to hear plenty of lively discussion about gene therapies, a new class of drugs that … |
